CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Nonrelated Party	Related Party	Preferred stock	Common stock	Common stock Nonrelated Party	Common stock Related Party	Additional paid-in Capital	Additional paid-in Capital Nonrelated Party	Additional paid-in Capital Related Party	Accumulated other comprehensive income (loss)	Accumulated deficit
Balance (in shares) at Dec. 31, 2023				2,369,797	19,875,427
Balance at Dec. 31, 2023	$ 405,333			$ 0	$ 2			$ 1,741,153			$ 468	$ (1,336,290)
Increase (Decrease) in Stockholders' Equity
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs (in shares)						750,000
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs		$ 311,560							$ 311,560
Sale of warrants to related parties in equity offerings, exercise of common stock options, and restricted stock vesting, net of transaction costs (in shares)							59,236
Sale of warrants to related parties in equity offerings, exercise of common stock options, and restricted stock vesting, net of transaction costs			$ 262,145							$ 262,145
Stock-based compensation expense related to equity-classified awards	19,902							19,902
Unrealized loss on marketable securities and foreign currency	(640)										(640)
Net loss	(147,541)											(147,541)
Balance (in shares) at Mar. 31, 2024				2,369,797	20,684,663
Balance at Mar. 31, 2024	850,759			$ 0	$ 2			2,334,760			(172)	(1,483,831)
Balance (in shares) at Dec. 31, 2023				2,369,797	19,875,427
Balance at Dec. 31, 2023	405,333			$ 0	$ 2			1,741,153			468	(1,336,290)
Increase (Decrease) in Stockholders' Equity
Net loss	(299,512)
Balance (in shares) at Jun. 30, 2024				2,369,797	21,700,893
Balance at Jun. 30, 2024	857,120			$ 0	$ 2			2,493,288			(368)	(1,635,802)
Balance (in shares) at Mar. 31, 2024				2,369,797	20,684,663
Balance at Mar. 31, 2024	850,759			$ 0	$ 2			2,334,760			(172)	(1,483,831)
Increase (Decrease) in Stockholders' Equity
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs (in shares)						346,153
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs		$ 85,950							$ 85,950
Sale of warrants to related parties in equity offerings, exercise of common stock options, and restricted stock vesting, net of transaction costs (in shares)							670,077
Sale of warrants to related parties in equity offerings, exercise of common stock options, and restricted stock vesting, net of transaction costs			$ 48,174							$ 48,174
Stock-based compensation expense related to equity-classified awards	24,404							24,404
Unrealized loss on marketable securities and foreign currency	(196)										(196)
Net loss	(151,971)											(151,971)
Balance (in shares) at Jun. 30, 2024				2,369,797	21,700,893
Balance at Jun. 30, 2024	$ 857,120			$ 0	$ 2			2,493,288			(368)	(1,635,802)
Balance (in shares) at Dec. 31, 2024	22,004,679			2,369,797	22,004,679
Balance at Dec. 31, 2024	$ 754,383			$ 0	$ 2			2,556,095			468	(1,802,182)
Increase (Decrease) in Stockholders' Equity
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs (in shares)					183,037
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs	8,640							8,640
Stock-based compensation expense related to equity-classified awards	20,931							20,931
Unrealized loss on marketable securities and foreign currency	(79)										(79)
Net loss	(73,238)											(73,238)
Balance (in shares) at Mar. 31, 2025				2,369,797	22,187,716
Balance at Mar. 31, 2025	$ 710,637			$ 0	$ 2			2,585,666			389	(1,875,420)
Balance (in shares) at Dec. 31, 2024	22,004,679			2,369,797	22,004,679
Balance at Dec. 31, 2024	$ 754,383			$ 0	$ 2			2,556,095			468	(1,802,182)
Increase (Decrease) in Stockholders' Equity
Sale of warrants to related parties in equity offerings, exercise of common stock options, and restricted stock vesting, net of transaction costs (in shares)	118,658
Net loss	$ (115,519)
Balance (in shares) at Jun. 30, 2025	22,221,116			2,369,797	22,221,116
Balance at Jun. 30, 2025	$ 695,978			$ 0	$ 2			2,612,566			1,111	(1,917,701)
Balance (in shares) at Mar. 31, 2025				2,369,797	22,187,716
Balance at Mar. 31, 2025	710,637			$ 0	$ 2			2,585,666			389	(1,875,420)
Increase (Decrease) in Stockholders' Equity
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs (in shares)					33,400
Issuance of common shares and sale of warrants in equity offerings, excluding to related parties, net of transaction costs	1,741							1,741
Stock-based compensation expense related to equity-classified awards	25,159							25,159
Unrealized loss on marketable securities and foreign currency	722										722
Net loss	$ (42,281)											(42,281)
Balance (in shares) at Jun. 30, 2025	22,221,116			2,369,797	22,221,116
Balance at Jun. 30, 2025	$ 695,978			$ 0	$ 2			$ 2,612,566			$ 1,111	$ (1,917,701)